Mechanistic clues in the cardioprotective effect of terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats

Cardiovascular Toxicology

Volumn 11, Issue 1, 2011, Pages 48-57

  Parveen, Adila ^a   Babbar, Rashmi ^a   Agarwal, Sarita ^a   Kotwani, Anita ^b   Fahim, Mohammad ^b,c  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b UNIVERSITY OF DELHI   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Antioxidants; Chronic heart failure; Cytokine; Isoproterenol; Left ventricle functions; Terminalia arjuna

Indexed keywords

CREATINE KINASE MB; FLUINDOSTATIN; GLUTATHIONE; ISOPRENALINE; LIPID; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TERMINALIA ARJUNA EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART DISEASE; HEART FAILURE; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CHRONIC DISEASE; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; FATTY ACIDS, MONOUNSATURATED; GLUTATHIONE; HEART FAILURE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; ISOPROTERENOL; LIPIDS; MALONDIALDEHYDE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PLANT BARK; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TERMINALIA; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

RATTUS; TERMINALIA ARJUNA;

EID: 79952767991     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-010-9099-2     Document Type: Article

References (39)

1. DM Lloyd-Jones MG Larson EP Leip A Beiser RB D'Agostino WB Kannel JM Murabito RS Vasan EJ Benjamin D Levy 2002 Lifetime risk for developing congestive heart failure: The Framingham heart study Circulation 106 3068 3072 10.1161/01.CIR.0000039105.49749.6F 12473553 (Pubitemid 35440290)
2. KK Ho JL Pinsky WB Kannel D Levy 1993 The epidemiology of heart failure: The Framingham Study Journal of the American College of Cardiology 22 6 13 10.1016/0735-1097(93)90455-A
3. CU Chae MA Pfeffer RJ Glynn GF Mitchell JO Taylor CH Hennekens 1999 Increased pulse pressure and risk of heart failure in the elderly JAMA 281 634 639 1:STN:280:DyaK1M7ltFGrsQ%3D%3D 10.1001/jama.281.7.634 10029125 (Pubitemid 29098064)
4. HL Middlekauff 1997 Mechanisms and implications of autonomic nervous system dysfunction in heart failure Current Opinion in Cardiology 12 265 275 1:STN:280:DyaK2szoslShsw%3D%3D 10.1097/00001573-199705000-00008 9243084
5. IH Zucker W Wang 1991 Reflex control of renal sympathetic nervous activity in heart failure Herz 16 82 91 1:STN:280:DyaK3M3ptlKqtA%3D%3D 2066056
6. GF DiBona LL Sawin 1995 Increased renal nerve activity in cardiac failure: Arterial vs. cardiac baroreflex impairment American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 268 112 116
7. B Levine J Kalman L Mayer HM Fillit M Packer 1990 Elevated circulating levels of tumour necrosis factor in severe chronic heart failure New England Journal of Medicine 323 236 241 1:STN:280:DyaK3czgvF2isA%3D%3D 10.1056/NEJM199007263230405 2195340 (Pubitemid 20225044)
8. U Landmesser S Spiekermann S Dikalov H Tatge R Wilke C Kohler DG Harrison B Hornig H Drexler 2002 Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine-oxidase and extracellular superoxide dismutase Circulation 106 3073 3078 1:CAS:528:DC%2BD38XptFKgsLo%3D 10.1161/01.CIR.0000041431.57222.AF 12473554 (Pubitemid 35440291)
9. AM Shah KM Channon 2004 Free radicals and redox signalling in cardiovascular disease Heart 90 486 487 1:CAS:528:DC%2BD2cXktlKgurk%3D 10.1136/hrt.2003.029389 15084535 (Pubitemid 38530157)
10. FJ Giardano 2005 Oxygen, oxidative stress, hypoxia, and heart failure Journal of Clinical Investigation 115 500 508
11. B Bozkurt SB Kribbs FJ Clubb LH Michael VV Didenko PJ Hornsby Y Seta H Oral FG Spinale DL Mann 1998 Pathophysiologically relevant concentrations of tumour necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1382 1391 1:CAS:528:DyaK1cXis1KqtL0%3D 9577950 (Pubitemid 28182677)
12. JGF Cleland I Gemmell A Khand A Body 1999 Is the prognosis of heart failure improving? European Journal of Heart Failure 1 229 241 1:STN:280:DC%2BD3cvgtlKjtw%3D%3D 10.1016/S1388-9842(99)00032-X 10935669 (Pubitemid 30129391)
13. TB Horwich WR MacLellan GC Fonarow 2004 Statin therapy is associated with improved survival in ischemic and nonischemic heart failure Journal of the American College of Cardiology 43 642 648 1:CAS:528:DC%2BD2cXitlaqsbc%3D 10.1016/j.jacc.2003.07.049 14975476 (Pubitemid 38229538)
14. JK Liao U Laufs 2005 Pleiotropic effects of statins Annual Review of Pharmacology and Toxicology 45 89 118 1:CAS:528:DC%2BD2MXisVWjtrY%3D 10.1146/annurev.pharmtox.45.120403.095748 15822172 (Pubitemid 40261799)
15. SM Grundy 2005 The issue of statin safety: Where do we stand? Circulation 111 3016 3019 10.1161/CIRCULATIONAHA.105.557652 15911705 (Pubitemid 40847775)
16. AM Gotto 2006 Statins, cardiovascular disease and drug safety American Journal of Cardiology 97 3C 5C 16581326
17. AB Vaidya 1994 Terminalia arjuna in cardiovascular therapy The Journal of the Association of Physicians of India 42 281 282 1:STN:280: DyaK2M7msVCmtA%3D%3D 7860542
18. R Gupta S Singhal A Goyle VN Sharma 2001 Antioxidant and hypocholesterolemic effects of Terminalia arjuna tree-bark powder: A randomized placebo-controlled trial The Journal of the Association of Physicians of India 49 231 235 1:STN:280:DC%2BD3M7otFeqsw%3D%3D 11225136
19. S Dwivedi 1994 Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary heart disease The Journal of the Association of Physicians of India 42 287 289 1:STN:280:DyaK2M7msVCmug%3D%3D 7741874
20. JR Teerlink JM Pfeffer MA Pfeffer 1998 Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse isoproterenol-induced myocardial necrosis Journal of Cardiac Failure 4 45 56 1:STN:280:DyaK1c3jsVGrtw%3D%3D 10.1016/S1071-9164(98)90507-3 9573503 (Pubitemid 28252540)
21. D Grimm D Elsner H Schunkert M Pfeffer D Griese G Bruckschlegel F Muders AJG Riegger EP Kromer 1998 Development of heart failure following isoproterenol administration in the rat: Role of the renin- angiotensin system Cardiovascular Research 37 91 100 1:CAS:528:DyaK1cXhtlKgsLc%3D 10.1016/S0008-6363(97)00212-5 9539862 (Pubitemid 28122620)
22. S Hayashidani H Tsutsui T Shiomi N Suematsu S Kinugawa T Ide J Wen A Takeshita 2002 Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 105 868 873 1:CAS:528:DC%2BD38XitlOls7c%3D 10.1161/hc0702.104164 11854129 (Pubitemid 34174929)
23. K Gauthaman M Maulik R Kumari SC Manchanda AK Dinda SK Maulik 2001 Effect of chronic treatment with bark of Terminalia Arjuna: A study on the isolated ischemic-reperfused rat heart Journal of Ethnopharmacology 75 197 201 1:STN:280:DC%2BD3M3htVGhuw%3D%3D 10.1016/S0378-8741(01)00183-0 11297851 (Pubitemid 32303141)
24. R Bos N Mougenot L Findji O Médiani PM Vanhoutte P Lechat 2005 Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist Journal of Cardiovascular Pharmacology 45 8 13 1:CAS:528: DC%2BD2cXhtFaitbzM 10.1097/00005344-200501000-00003 15613973 (Pubitemid 40039749)
25. G Rona 1985 Catecholamine cardiotoxicity Journal of Molecular and Cellular Cardiology 17 291 306 1:CAS:528:DyaL2MXkvVWrs7Y%3D 10.1016/S0022- 2828(85)80130-9 3894676 (Pubitemid 15030720)
26. JC Yeager SG Iams 1981 The hemodynamics of isoproterenol-induced cardiac failure in the rat Circulatory Shock 8 151 163 1:CAS:528:DyaL3MXktVSlsbo%3D 7226440 (Pubitemid 11077993)
27. 2+ transport due to excess catecholamines Cardiovascular Drugs and Therapy 10 231 238 10.1007/BF00120492 8827945 (Pubitemid 26191028)
28. PK Singal RE Beamich NS Dhalla 1983 Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease Advances in Experimental Medicine and Biology 161 391 440 1:CAS:528: DyaL3sXks1ygurg%3D 6869078
29. D Grimm SR Holmer GAJ Riegger EP Kromer 1999 Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol- induced heart failure in the rat Cardiovascular Pathology 8 315 323 1:CAS:528:DyaK1MXnsVKlt7Y%3D 10.1016/S1054-8807(99)00021-6 10615017
30. P Balakumar M Singh 2006 The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats Basic and Clinical Pharmacology and Toxicology 99 418 424 1:CAS:528:DC%2BD2sXhs1WisQ%3D%3D 10.1111/j.1742-7843. 2006.pto-569.x 17169122 (Pubitemid 44813909)
31. DZ Zhong CX Min S Siyu D Dan C Hui 2008 From neuroendocrine activation to intracardiac cyclic nucleotides in chronic heart failure of rats induced by isoproterenol Journal of Chinese Clinical Medicine 3 601 608
32. JC Yeager ME Whitehurst 1982 Verapamil prevents isoproterenol induced cardiac failure in rats Life Sciences 30 299 306 1:CAS:528:DyaL38XhtFGlurk%3D 10.1016/0024-3205(82)90512-4 7070210 (Pubitemid 12072185)
33. JR Teerlink JM Pfeffer MA Pfeffer 1994 Progressive ventricular remodeling in response to diffuse isoproterenol- induced myocardial necrosis in rats Circulation Research 75 105 113 1:STN:280:DyaK2c3ot1yksQ%3D%3D 8013068
34. C Nirmala R Puvanakrishnan 1996 Protective role of curcumin against isoproterenol induced myocardial infarction in rats Molecular and Cellular Biochemistry 159 85 93 1:CAS:528:DyaK28XkvVOju7k%3D 10.1007/BF00420910 8858558 (Pubitemid 26252465)
35. R Zhou Q Xu P Zheng L Yan J Zheng G Dai 2008 Cardioprotective effect of fluvastatin on Isoproterenol-induced myocardial infarction in rat European Journal of Pharmacology 586 244 250 1:CAS:528:DC%2BD1cXmsVGmtLw%3D 10.1016/j.ejphar.2008.02.057 18384769
36. S Kumar R Enjamoori A Jaiswal R Ray S Seth SK Maulik 2009 Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.) The Journal of Pharmacy and Pharmacology 61 1529 1536 1:CAS:528:DC%2BC3cXitFGqsLY%3D 19903379
37. M Rajadurai PSM Prince 2006 Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats Journal of Biochemical and Molecular Toxicology 20 191 197 1:CAS:528:DC%2BD28XovFGmsro%3D 10.1002/jbt.20136 16906524 (Pubitemid 44384709)
38. DL Mann 2005 Targeted anticytokine therapy and the failing heart American Journal of Cardiology 95 9 16 10.1016/j.amjcard.2005.03.007 (Pubitemid 40755513)
39. K Node M Fujita M Kitakaze M Hori JK Liao 2003 Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 839 843 1:CAS:528:DC%2BD3sXmtFCisbc%3D 10.1161/01.CIR.0000084539.58092.DE 12885745 (Pubitemid 37022126)